Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hera BioLabs
Lexington, Kentucky, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Hera BioLabs provides validated preclinical animal models (not therapeutics) for drug efficacy, safety, and toxicity studies, including the highly immunocompromised SRG rat (OncoRat), which supports high tumor take-rates for xenograft studies; current offerings are non-clinical research tools, not direct therapeutics[1][3][4].
- Therapeutic areas
- OncologyInfectious DiseasesOther
- Modalities
- Gene editing technologyRecombinant proteinCell engineering
- Industry
- Non-Drug Biotech
02
Partnerships
Charles River Laboratories (global license and commercialization of SRG rat/OncoRat)[3]
Beyond the preview
Go deeper on Hera BioLabs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hera BioLabs.